ZEP-3Na
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ZEP-3Na, covering 2023-09-13 to 2023-09-13. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic Dermatitis [Phase 2]